Literature DB >> 22128262

Inhibitory actions of HERG currents by the immunosuppressant drug cyclosporin a.

Seung Ho Lee1, Sang June Hahn, Gyesik Min, Jimok Kim, Su-Hyun Jo, Han Choe, Bok Hee Choi.   

Abstract

The effect of cyclosporin A (CsA), an immunosuppressant, on human ether-a-go-go-related gene (HERG) channel as it is expressed in human embryonic kidney cells was studied using a whole-cell, patch-clamp technique. CsA inhibited the HERG channel in a concentration-dependent manner, with an IC(50) value and a Hill coefficient of 3.17 µM and 0.89, respectively. Pretreatment with cypermethrine, a calcineurin inhibitor, had no effect on the CsA-induced inhibition of the HERG channel. The CsA-induced inhibition of HERG channels was voltage-dependent, with a steep increase over the voltage range of the channel opening. However, the inhibition exhibited voltage independence over the voltage range of fully activated channels. CsA blocked the HERG channels predominantly in the open and inactivated states rather than in the closed state. Results of the present study suggest that CsA acts directly on the HERG channel as an open-channel blocker, and it acts independently of its effect on calcineurin activity.

Entities:  

Keywords:  Cyclosporin A; HERG; Immunosuppressant; Long QT syndrome; Open channel block

Year:  2011        PMID: 22128262      PMCID: PMC3222799          DOI: 10.4196/kjpp.2011.15.5.291

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  23 in total

1.  Blockade of HERG human K+ channels and IKr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine.

Authors:  So-Young Lee; Young-Jin Kim; Kyong-Tai Kim; Han Choe; Su-Hyun Jo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

Review 2.  Disease, destination, dose and delivery aspects of ciclosporin: the state of the art.

Authors:  Jagdish L Italia; Vivekanand Bhardwaj; M N V Ravi Kumar
Journal:  Drug Discov Today       Date:  2006-09       Impact factor: 7.851

3.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  J Gen Physiol       Date:  1990-07       Impact factor: 4.086

4.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.

Authors:  Z Zhou; Q Gong; B Ye; Z Fan; J C Makielski; G A Robertson; C T January
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

Review 5.  Mechanisms of action of cyclosporine.

Authors:  S Matsuda; S Koyasu
Journal:  Immunopharmacology       Date:  2000-05

6.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

7.  Immunophilin regulation of neurotransmitter release.

Authors:  J P Steiner; T M Dawson; M Fotuhi; S H Snyder
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

8.  HERG, a human inward rectifier in the voltage-gated potassium channel family.

Authors:  M C Trudeau; J W Warmke; B Ganetzky; G A Robertson
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

9.  Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits.

Authors:  S L Cockerill; A B Tobin; I Torrecilla; G B Willars; N B Standen; J S Mitcheson
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

Review 10.  Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications.

Authors:  M Taglialatela; P Castaldo; A Pannaccione; G Giorgio; L Annunziato
Journal:  Biochem Pharmacol       Date:  1998-06-01       Impact factor: 5.858

View more
  2 in total

1.  Taxifolin Glycoside Blocks Human ether-a-go-go Related Gene K(+) Channels.

Authors:  Jihyun Yun; Hyemi Bae; Sun Eun Choi; Jung-Ha Kim; Young Wook Choi; Inja Lim; Chung Soo Lee; Min Won Lee; Jae-Hong Ko; Seong Jun Seo; Hyoweon Bang
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

2.  Differential effects of tautomycetin and its derivatives on protein phosphatase inhibition, immunosuppressive function and antitumor activity.

Authors:  Mingshan Niu; Yan Sun; Bo Liu; Li Tang; Rongguo Qiu
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.